title: Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients.
abstract: Increasing evidence suggests that adipocyte function is altered in the polycystic ovary syndrome (PCOS) as a result of androgen excess, providing an explanation for its frequent association with abdominal adiposity and insulin resistance. We here compared the response of serum adiponectin and leptin levels to the amelioration of androgen excess by means of treatment with an antiandrogenic oral contraceptive pill, as compared with the response to insulin sensitization with metformin. Thirty-four women presenting with PCOS were randomized to treatment with an oral contraceptive containing 35 microg ethinyl-estradiol plus 2 mg cyproterone acetate (Diane(35) Diario) or with metformin (850 mg twice daily). Serum adiponectin and leptin levels were evaluated at baseline and after 12 and 24 weeks of treatment. In obese PCOS women, treatment with Diane(35) Diario resulted in an increase in serum adiponectin levels and in the adiponectin/leptin ratio, in parallel with a marked decrease in serum androgen concentrations, whereas no statistically significant changes were observed during treatment with metformin. On the contrary, leptin concentrations did not show any statistically significant change during the study with any of the drugs studied here. In summary, our present results might suggest a direct inhibitory effect of androgen excess on adiponectin secretion by adipocytes in obese PCOS women, supporting the hypothesis that androgen excess contributes to adipocyte dysfunction in these women.
authors.affiliation: Department of Endocrinology, Hospital Universitario Ramón y Cajal & Universidad de Alcalá, Madrid, Spain.
authors.forename: Manuel
authors.initials: M
authors.lastname: Luque-Ramírez
authors.forename: Francisco
authors.initials: F
authors.lastname: Alvarez-Blasco
authors.forename: Héctor F
authors.initials: HF
authors.lastname: Escobar-Morreale
mesh_terms: D017667:Adipocytes / Q000187:drug effects / Q000502:physiology; D052242:Adiponectin / Q000097:blood*; D000273:Adipose Tissue / Q000033:anatomy & histology; D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use*; D019540:Area Under Curve; D001835:Body Weight; D003276:Contraceptives, Oral / Q000494:pharmacology*; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood; D008687:Metformin / Q000494:pharmacology; D009765:Obesity / Q000097:blood*; D011085:Polycystic Ovary Syndrome / Q000097:blood*; D013739:Testosterone / Q000097:blood; D055815:Young Adult
chemical_list: D052242:Adiponectin; D000726:Androgen Antagonists; D003276:Contraceptives, Oral; D007328:Insulin; D020738:Leptin; D013739:Testosterone; D019314:Dehydroepiandrosterone Sulfate; D008687:Metformin